Skip to main content
. 2014 Oct 23;26(12):1792–1801. doi: 10.1111/nmo.12463

Figure 1.

Figure 1

Study schema. Dose titration was permitted at the discretion of the investigator to a maximum of 80 mg/day (OXN3001S) or 120 mg/day (OXN3006S). OXN PR, combined oxycodone / naloxone prolonged-release tablets; Oxy PR, oxycodone prolonged-release; R, randomization.